PRODUCT DETAILS

About Affovog-M 2 Tablet SR

VOGLIBOSE+METFORMIN belongs to the class of anti-diabetic drugs. It is used in the treatment of type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produces little or no insulin at all.

Uses of Affovog-M 2 Tablet SR

Type 2 Diabetes mellitus.

Medicinal Benefits of Affovog-M 2 Tablet SR

VOGLIBOSE+METFORMIN is used to treat type 2 diabetes mellitus. It is a combination of Voglibose and Metformin. Voglibose belongs to the class of alpha-glucosidase inhibitors. It delays glucose absorption by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels immediately after meals. Metformin belongs to the class of biguanides. It shows the non-pancreatic effect to reduce serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. It is considered to be a unique anti-diabetic drug since it does not lower blood sugar levels. Metformin does not cause weight gain in most cases.

Directions for Use

Tablet: Swallow it as a whole with water; do not crush, break or chew it. Take VOGLIBOSE+METFORMIN preferably with a meal, since it lowers the blood sugar levels and causes gastrointestinal side effects. Your doctor may start the course with a low dose and gradually maintain an effective dose to achieve the required blood glucose control.

Side Effects of Affovog-M 2 Tablet SR

• Nausea
• Vomiting
• Changes in taste
• Diarrhoea
• Dizziness
• Stomach pain
• Shortness of breath
• Skin rash
• Bloating
• Flatulence (intestinal wind/gas)

Rare side effects:

• Lactic acidosis

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

VOGLIBOSE+METFORMIN may increase the risk of cardiovascular diseases and hypoglycemic conditions in renal and liver disease patients. It can cause pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs. It is advised to monitor the gastrointestinal side effects thoroughly to rule out the possibility of pneumatosis intestinalis. VOGLIBOSE+METFORMIN has an increased risk of lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation). The risk of lactic acidosis is high in older people with kidney, liver, and heart diseases. Hence, brief your medical history and take advice from your doctor before starting VOGLIBOSE+METFORMIN. Avoid consuming excessive alcohol as it can potentiate lactic acidosis.

Drug Interactions

Drug-Drug Interaction:

VOGLIBOSE+METFORMIN may interact with anti-depressants (selegiline, isocarboxazid, phenelzine), anti-inflammatory drugs (prednisolone, phenylbutazone), drugs that treat fluid retention (metolazone, hydrochlorothiazide, chlorothiazide), medicines used to treat high blood pressure (propranolol, metoprolol), anabolic, and corticosteroids. Please check the instruction leaflet that comes with the medication before you take VOGLIBOSE+METFORMI

Drug-Disease Interaction:

 Tell your doctor before taking VOGLIBOSE+METFORMIN if you have a medical history of allergic reactions to medicines, heart diseases, liver, and kidney problems. VOGLIBOSE+METFORMIN may cause pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs.

Safety Advice

ALCOHOL

• It is unsafe to consume alcohol since it may worsen the side effects.

PREGNANCY

• Please consult your doctor before starting VOGLIBOSE+METFORMIN if you are pregnant or planning to conceive.

BREAST FEEDING

• There is no sufficient data on how VOGLIBOSE+METFORMIN affects breastfeeding. It is safe to seek medical advice before you start VOGLIBOSE+METFORMIN if you are lactating.

DRIVING

• Your driving ability may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience dizziness or drowsiness.

LIVER

• Let your doctor know if you have any history of liver diseases or hepatic impairment when you are prescribed VOGLIBOSE+METFORMIN.

KIDNEY

• Let your doctor know if you have any history of kidney diseases when you are prescribed VOGLIBOSE+METFORMIN.